ATG7 Blocking Peptide Summary
A blocking peptide from human ATG7.
Source: Synthetic
Blocking Peptide
ATG7
>95%, by HPLC
Applications/Dilutions
Control peptide for NB600-1274 should be used at 1.0 ug per 1.0 ul of antiserum in per assay.
Packaging, Storage & Formulations
Store at -20C short term. Aliquot and store at -80C long term. Avoid freeze-thaw cycles.
0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
No Preservative
1.0 mg/ml
>95%, by HPLC
Alternate Names for ATG7 Blocking Peptide
- APG7 autophagy 7-like (S. cerevisiae)
- APG7
- APG7L
- APG7-LIKE
- ATG12-activating enzyme E1 ATG7
- ATG7 autophagy related 7 homolog (S. cerevisiae)
- ATG7
- Autophagy-related protein 7
- DKFZp434N0735
- GSA7
- hAGP7
- ubiquitin activating enzyme E1-like protein
- Ubiquitin-activating enzyme E1-like protein
- ubiquitin-like modifier-activating enzyme ATG7
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.
product targets :　Hexokinase inhibitors